Simplify Logo

Full-Time

Vice President

Analytical Development

Posted on 6/27/2024

Verve Therapeutics

Verve Therapeutics

201-500 employees

Developing gene editing therapies for heart disease

Hardware
Biotechnology
Healthcare

Compensation Overview

$288k - $360kAnnually

Senior

Cambridge, MA, USA

Category
Biology Lab & Research
Biology & Biotech
Requirements
  • Demonstrated history of effective leadership
  • Experience with method development, qualification, and validation for clinical and commercial products
  • Experience in characterization of advanced therapies, ideally gene editing, RNA, and/or LNP products
  • Experience with international regulatory interactions
  • Excellent written and verbal communication skills
  • BS in sciences, analytical chemistry, biochemistry, pharmacy, or related area, advanced degree preferred with 15+ years of progressive leadership experience
Responsibilities
  • Lead and grow a team of analytical scientists and research associates
  • Developing and optimizing analytical assays across different stages of drug development
  • Testing non-GMP samples to support development studies
  • Collaborating closely with the R&D and Quality Control teams
  • Enhancing product and process understanding by characterizing impurities
  • Improve lab management and operations
  • Write and review regulatory filings and briefing books
  • Promote a culture of continuous improvement and collaboration

Verve Therapeutics is developing single-course gene editing medicines to address cardiovascular disease, with a focus on precision genetic editing technologies to lower LDL cholesterol and triglyceride levels. Their lead program, VERVE-101, targets heterozygous familial hypercholesterolemia, a potentially fatal genetic heart disease.

Company Stage

IPO

Total Funding

$419.3M

Headquarters

Cambridge, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

7%

1 year growth

5%

2 year growth

54%
INACTIVE